Get the Stockscreener App
25.40
3.47%
0.857
Azenta Inc stock is traded at $25.40, with a volume of 641.08K.
It is up +3.47% in the last 24 hours and down -10.87% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$24.54
Open:
$24.94
24h Volume:
641.08K
Relative Volume:
0.85
Market Cap:
$1.17B
Revenue:
$595.19M
Net Income/Loss:
$28.96M
P/E Ratio:
-20.03
EPS:
-1.2679
Net Cash Flow:
$30.93M
1W Performance:
-8.92%
1M Performance:
-10.87%
6M Performance:
-13.98%
1Y Performance:
-38.17%
1-Day Range:
$24.60
$25.91
1-Week Range:
$23.77
$28.12
52-Week Range:
$23.77
$45.26
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
25.41 | 1.13B | 595.19M | 28.96M | 30.93M | -1.2679 |
|
ISRG
Intuitive Surgical Inc
|
501.81 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.24 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.01 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.95 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.16 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta Acquires UK Biocentre to Expand European Biorepository - TipRanks
Azenta acquires UK Biocentre for £20.5 million - Investing.com India
Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities - marketscreener.com
Azenta to Acquire UK Biocentre for GBP 20.5 Million to Build European SRS Hub - TradingView
Azenta (AZTA) acquires UK Biocentre in GBP 20.5m European hub deal - Stock Titan
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - PR Newswire
Vanguard Group Inc. Lowers Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (AZTA) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Has $9.88 Million Position in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Short Interest Update - MarketBeat
Azenta stock hits 52-week low at 23.88 USD By Investing.com - Investing.com Canada
Azenta at 47th Annual Raymond James Conference: Strategic Turnaround Insights - Investing.com
AZTA SEC FilingsAzenta Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta, Inc. (NASDAQ:AZTA) Given Average Rating of "Hold" by Brokerages - MarketBeat
3 Reasons AZTA is Risky and 1 Stock to Buy Instead - Finviz
AZTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Rate Hike: Can Azenta Inc keep up with sector leaders2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta schedules Raymond James investor talk with 4 p.m. webcast - Stock Titan
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - Finviz
Rate Cut: Will Azenta Inc benefit from rising consumer demand2025 Market Trends & Accurate Technical Buy Alerts - baoquankhu1.vn
Jupiter Asset Management Ltd. Purchases 77,869 Shares of Azenta, Inc. $AZTA - MarketBeat
Will Azenta Inc. stock continue upward momentum2025 Sector Review & Weekly High Return Opportunities - mfd.ru
Decliners Report: Will Azenta Inc benefit from sector rotationQuarterly Risk Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Microgravity Trial Advances Space Lab Research - Technology Networks
Can Azenta Inc. grow without external fundingJuly 2025 WrapUp & Daily Profit Focused Screening - mfd.ru
KeyBanc reiterates Sector Weight on Azenta stock after conference By Investing.com - Investing.com South Africa
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (AZTA) Stock Analysis: Is A 35.10% Potential Upside Worth Considering? - DirectorsTalk Interviews
KeyBanc reiterates Sector Weight on Azenta stock after conference - Investing.com
A Look At Azenta (AZTA) Valuation After Its Transitional Earnings Update - Yahoo Finance
Azenta’s Space Research Partnership Sparks Questions On Valuation And Growth Potential - Yahoo Finance
Azenta to Participate in the Stephens Annual Investment Conferen - GuruFocus
Why Azenta Inc. stock appeals to analystsJuly 2025 Setups & Daily Profit Focused Stock Screening - mfd.ru
Can Azenta Inc. stock surprise with earnings upsideJuly 2025 Decliners & Low Risk Growth Stock Ideas - mfd.ru
Caprock Group LLC Invests $1.64 Million in Azenta, Inc. $AZTA - MarketBeat
AlphaQuest LLC Decreases Stake in Azenta, Inc. $AZTA - MarketBeat
Can Azenta Inc. stock deliver surprise earnings beat2025 Trading Volume Trends & Low Volatility Stock Recommendations - mfd.ru
Is Azenta Inc. stock trending bullishQuarterly Profit Report & Free Community Consensus Stock Picks - mfd.ru
Azenta’s Space Trials Put Sample Tools And Valuation In New Focus - Sahm
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know - Yahoo Finance
Azenta (AZTA) price target increased by 15.88% to 39.34 - MSN
Azenta announces $250 million share repurchase program - MSN
Can Azenta Inc. keep up with sector leaders2025 Support & Resistance & Daily Profit Maximizing Tips - mfd.ru
Will Mesa Laboratories Inc benefit from sector rotationJuly 2025 Opening Moves & Community Verified Trade Alerts - baoquankhu1.vn
Is Azenta Inc. benefiting from innovation trendsQuarterly Growth Report & Free Daily Entry Point Trade Alerts - mfd.ru
Will Azenta Inc. benefit from rising consumer demandBond Market & Daily Stock Trend Watchlist - mfd.ru
Bio-Preservation Market to Reach US$ 44.45 Billion by 2035 | Cold Chain Expansion and Cell & Gene Therapy Commercialization Drive Growth Says Astute Analytica - GlobeNewswire Inc.
The Top 5 Analyst Questions From Azenta's Q4 Earnings Call - Finviz
The Top 5 Analyst Questions From Azenta’s Q4 Earnings Call - Barchart.com
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Azenta Inc Stock (AZTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
0.98%
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):